Chief Medical Officer
Chief Medical Officer at Spyre Therapeutics, Inc., filing insider transactions between 2026-04-01 and 2026-07-01.
| SEC ↗ |
| 2026-05-01 | SYRE | Sale | 19.7K | $70.61 | $1.4M | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 21.3K | $69.53 | $1.5M | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 400 | $75.37 | $30K | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 5,059 | $74.60 | $377K | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 8,777 | $71.56 | $628K | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 10.4K | $73.74 | $764K | SEC ↗ |
| 2026-05-01 | SYRE | Sale | 12.8K | $72.94 | $932K | SEC ↗ |
| 2026-04-01 | SYRE | Sale | 7,958 | $50.00 | $398K | SEC ↗ |